PR Newswire Clinical TrialsOriginal article
FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing
Patent Expiry3D Spheroid FibroblastsFibroblast-Derived MaterialsPositive
AI Analysis
Summary
FibroBiologics announced the issuance of a new U.S. patent covering the therapeutic use of topical 3D spheroid fibroblasts and fibroblast-derived materials for wound healing treatment and acceleration.
Outcome Details
New U.S. patent issued for therapeutic use of fibroblasts in wound healing, covering topical administration of 3D spheroid fibroblasts and fibroblast-derived materials
Importance:4/10
Sentiment:
0.40
patentwound healingfibroblastsIP protection
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on September 3, 2026 12:30 PM